Why ECPC Matters
The challenge of access to medicines is of crucial importance to millions of Europeans affected by cancer every year. Whilst no one country is immune to access issues, some regions and countries in Europe face greater difficulties than others. Several factors have an impact on access to medicines, from regulatory standards to funding systems and the varying nature of healthcare systems across Europe – all adding to inequalities across Europe. The European Parliament adopted a report, on its own initiative, on the ‘Options for Improving Access to Medicines’ – presenting an opportunity for the European Parliament to take a proactive stance on the issue of access to medicines. It makes several calls for action aimed at EU and Member State institutions to address the most urgent challenges when it comes to access to medicines, stressing the added value of European cooperation.
Annual Congress 2023 & Anniversary 20 years
Collaboration, Networking. Listening to the needs of cancer patients:
The essence of EU’s Beating Cancer Plan and Cancer Mission
June 23 – 24, 2023
Annual General Meeting
ECPC advocates 20 years to unite & make the European cancer patients voice heard.
June 25, 2023 – Renaissance Hotel Brussels
Personalised Medicine Booklet
ECPC together with ecancer has launched a new toolkit to provide patients with a comprehensive resource on genetic and genomic tests. The new resource will help patients and their families understanding them and make an informed choice.